Four ways pharma companies can make their supply chains more resilient

According to the latest Forbes article about Drug Shortages, in the past ten years, we have seen more drugs in short supply than ever before—and crucially, these shortages have lasted even longer than usual.


Research from McKinsey & Company shows that drug shortages in the United States have nearly tripled since 2005, costing hospitals more than half a billion dollars. This creates disruptions in the supply chain, resulting in increased spending for hospital pharmacies and out-of-pocket costs for patients. It can also present a severe risk to patient safety.


This McKinsey article discusses four ways pharma companies can make their supply chains more resilient.


Chapters included:

-Disruptions have become commonplace

-Regional dependencies and potential supply-chain shifts

-Four ways to build supply-chain resilience


https://lnkd.in/dpPEdTaa